Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
KSHN001126 150mg
Amneal Pharma Europe Ltd
Healthy Postmenopausal Women
1 trial -
KT-474/Placebo
Kymera Therapeutics
Healthy Volunteer
1 trial -
KT-579
Kymera Therapeutics
Healthy Participants
1 trial -
KT-621
Kymera Therapeutics
Healthy Participants Study
1 trial -
Ketamine
Takeda
Healthy
1 trial -
Kukoamine B Mesilate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
LDX + Venlafaxine XR
Takeda
Healthy
1 trial -
LIDEXU
Lacuna Pharma Pty Ltd
bioavailability trial with healthy participants, therapeutic indication not studied
1 trial -
LX4211
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
LX4211 400 mg
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
LX4211 400 mg
LEXICON PHARMACEUTICALS, INC.
Healthy Subjects
1 trial -
LX4211 800 mg
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
LY3053102
Eli Lilly and Company
Healthy Volunteers
1 trial -
LY3209590 (SC)
Eli Lilly and Company
Healthy
1 trial -
LY3471851
Nektar Therapeutics UK Limited
Healthy
4 trials -
LY3493269
Eli Lilly and Company
Healthy
1 trial -
LY3493269 - SC
Eli Lilly and Company
Healthy
1 trial -
LY3537021
Eli Lilly and Company
Healthy
1 trial -
LY3819469
Eli Lilly and Company
Healthy
1 trial -
Lamotrigine
Teva Pharma GmbH
Healthy
2 trials -
Lamotrigine 25 mg Chewable Tablets
Teva Pharma GmbH
Healthy
2 trials -
Lamotrigine Extended Release
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Lanadelumab
Takeda
Healthy Volunteers
2 trials -
Lansoprazole
PUMA BIOTECHNOLOGY, INC.
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.